Latest news

Thumbnail image for ViiV unveils positive data for two-drug HIV regimens

ViiV unveils positive data for two-drug HIV regimens

ViiV Healthcare has unveiled positive clinical data for two two-drug HIV regimens ay the 22nd International AIDS conference in Amsterdam, showing long-term efficacy and non-inferiority to a current standard of care.

25th July 2018

Thumbnail image for US approves AbbVie/Neurocrine’s uterine pain drug

US approves AbbVie/Neurocrine’s uterine pain drug

AbbVie and Neurocrine have announced the US approval of Orilissa, the first and only oral gonadotropin-releasing hormone (GnRH) antagonist specifically developed for women with moderate to severe endometriosis pain.

25th July 2018

Thumbnail image for JCVI backs HPV jab for boys

JCVI backs HPV jab for boys

Government advisors are recommending that the national HPV immunisation programme in England should include boys as well as girls.

24th July 2018

Thumbnail image for Lilly to progress Olumiant into PhIII for lupus

Lilly to progress Olumiant into PhIII for lupus

The Lancet has published full results of a Phase II trial showing the benefit of Lilly’s JAK inhibitor Olumiant in the treatment of global systemic lupus erythematosus (SLE).

24th July 2018

Thumbnail image for Lilly links with Anima

Lilly links with Anima

Eli Lilly is teaming up with Anima Biotech in an exclusive collaboration to discover and develop translation inhibitors for several protein targets.

24th July 2018

Thumbnail image for FDA staff question efficacy of GSK’s Nucala for COPD

FDA staff question efficacy of GSK’s Nucala for COPD

US regulatory advisors are questioning the effectiveness of GlaxoSmithKline’s biologic Nucala as a treatment for patients experiencing a sudden worsening of chronic obstructive pulmonary disorder (COPD).

24th July 2018

Thumbnail image for GSK considers splitting up

GSK considers splitting up

GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.

23rd July 2018

Thumbnail image for Pfizer bags approval for Neupogen biosimilar

Pfizer bags approval for Neupogen biosimilar

Pfizer’s Neupogen biosimilar Nivestym has been approved by the US Food and Drug Administration and is expected to hit the market at a “significant discount” to its reference drug.

23rd July 2018

Thumbnail image for PureTech lifted by news of Roche deal

PureTech lifted by news of Roche deal

Shares in UK-based clinical-stage biopharm PureTech Health have been given a boost by news that Roche has signed up to advance its exosome platform technology in a deal potentially worth more than $1 billion.

20th July 2018

Previous  --   14 15 16 17 18 19 20 21 22 23   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download